8-K: DarioHealth Amends Charter, Board Gains Bylaw Authority

DarioHealth Corp. has amended its Certificate of Incorporation to explicitly grant its Board of Directors the power to alter and repeal company bylaws, a change approved by stockholders.

Summary

• DarioHealth Corp. filed an Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on February 2, 2026.
• The amendment expressly authorizes the Board of Directors to alter and repeal the company's bylaws.
• This authority is subject to the power of the company's stockholders to also alter or repeal the bylaws.
• The Amended Charter was approved by the company's stockholders at the annual meeting held on January 29, 2026.
• The filing also re-states the authorized capital stock: 400,000,000 shares of Common Stock (par value $0.0001 per share) and 5,000,000 shares of Preferred Stock (par value $0.0001 per share), totaling 405,000,000 authorized shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive governance update. It clarifies board authority and aligns with standard corporate practices, without indicating any immediate operational or financial impact.

Positives

• The amendment clarifies and potentially streamlines the process for updating corporate bylaws, allowing the Board to respond more efficiently to governance needs.
• Stockholder approval of the Amended Charter indicates alignment between management and shareholders on this governance change.

Future Outlook

No specific forward-looking statements or guidance are provided in this filing, as it pertains solely to a corporate governance amendment.

Management Comments

• The Corporation may, to the fullest extent permitted by Section 145 of the Delaware General Corporation Law, as the same may be amended and supplemented, indemnify any and all persons whom it shall have power to indemnify under said section.
• No director shall be personally liable to the Corporation or its stockholders for monetary damages for any breach of fiduciary duty by such director as a director, except for specific statutory exceptions.

Industry Context

StockSavvy.ai notes that granting the board explicit authority to amend bylaws, while subject to stockholder power, is a common corporate governance practice. It can enhance operational flexibility and responsiveness for companies, particularly in dynamic industries like digital health. This type of amendment generally aligns with modern corporate governance frameworks that seek to balance board efficiency with shareholder oversight.

Comparison to Industry Standards

• The authorization of 400,000,000 common shares and 5,000,000 preferred shares is a typical structure for publicly traded companies, providing flexibility for future equity financing or strategic transactions without immediate dilution.
• The indemnification provisions for directors and officers, and the limitation of director liability, are standard practices for Delaware corporations, consistent with Section 145 and Section 102(b)(7) of the Delaware General Corporation Law. Companies like Teladoc Health (TDOC) and Livongo (now part of TDOC) also operate under similar governance structures to protect their board members and attract talent.

Corporate Governance

Stakeholder Impact

• Shareholders: The amendment clarifies governance structure, potentially leading to more efficient board operations. Their power to alter or repeal bylaws is preserved.
• Board of Directors: Gains explicit authority to manage bylaws, which could improve responsiveness to corporate needs.
• Management: Benefits from clearer governance guidelines and board flexibility.

Key Dates

Recommendation

This filing is a routine corporate governance update that clarifies the Board's authority regarding bylaws and re-states the capital structure. It does not contain any information that would fundamentally alter the company's financial prospects, operational performance, or competitive position. Therefore, it is unlikely to significantly impact the stock price, warranting a "hold" recommendation for existing investors and no strong directional call for new investors based solely on this filing.

Keywords

DarioHealth, DRIO, SEC Filing, 8-K, Corporate Governance, Certificate of Incorporation, Bylaws, Board of Directors, Stockholder Approval, Delaware Corporation Law